R

RGEN

Repligen

144.75

-0.48-0.33%
After Hours: 146.97  +2.22  +1.53%19:54 04/25 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE143.75/145.23
TODAY RANGE140.89-145.96
VOL440.77K
MARKET CAP8.13B
52 WEEK RANGE102.97-182.52
AVG VOL (3M)771.05K
% TURNOVER0.78%
TURNOVER--
P/E (TTM)-317.3646
% RANGE3.49%
EPS(TTM)-0.4561
P/E(FORWARD)151.57
P/B4.116
BVPS35.17
DIVIDEND--
P/S12.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.61B
SHARES OUTSTANDING56.18M
NEXT EARNINGS--
FREE FLOAT52.56M
LOT SIZE1
EX-DIV DATE--
Same Industry
Name/Symbol
Change%
Price

R

Repligen

RGEN

-0.33%
144.75

A

Atrion Corp

ATRI

0.00%
459.92

I

IDEXX Laboratories

IDXX

-0.80%
437.44

C

Cencora Inc.

COR

+1.24%
285.90

T

Teleflex Inc

TFX

-0.33%
135.21

S

Stryker Corp

SYK

+1.11%
365.06

W

West Pharm Svcs

WST

+1.88%
214.55

U

Ufp Technologies

UFPT

-0.04%
206.80

S

Shockwave Medical, Inc.

SWAV

0.00%
334.75

C

Cooper

COO

-2.05%
80.89

B

Becton Dickinson & Co

BDX

+0.31%
205.08

B

Becton Dickinson And Co

BDXB

--
48.16

U

Utah Med Prods

UTMD

-0.95%
52.37

A

Align Technology Inc

ALGN

-0.50%
183.35

H

Henry Schein

HSIC

-1.60%
65.17

G

Ge Healthcare Technologies Inc

GEHC

+2.05%
68.42

A

Abbott Labs

ABT

-0.41%
128.85

C

Conmed Corp

CNMD

-0.57%
50.71

M

Medtronic

MDT

-0.17%
84.16

Z

Zimmer Biomet

ZBH

+0.01%
101.51

B

BECTON DICKINSON

BDXA

--
0.0000
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.